Roche unveils new analytical units for cobas pro integrated solutions in countries accepting CE mark

“Today more than ever, accurate and timely diagnostics is critical for effective delivery of healthcare. Labs are under increasing pressure to process more samples, at greater speed without compromising on accuracy,” said Matt Sause, CEO of Roche Diagnostics.“With the launch of the cobas c 703 and cobas ISE neo, we are taking our latest generation clinical chemistry and immunochemistry platform, the cobas pro integrated solutions, to the next level. By integrating high-volume clinical chemistry testing and increased automation, we will set a new standard for high volume testing in the clinical lab.”

The new cobas c 703 analytical unit is designed to double the clinical chemistry throughput on cobas pro integrated solutions, offering up to 2,000 tests per hour and 70 reagent positions. This increased onboard reagent capacity means more high-value tests can be performed whilst improving workflow efficiency and saving time spent reloading reagents. This new unit will minimise operator maintenance to once a month, increasing uptime for laboratories.

The cobas ISE neo is designed to improve ion selective electrode (ISE) testing efficiency, offering up to 1,800 tests per hour. With a number of hardware and software features, including an automated calibration concept, it significantly reduces the need for manual intervention. It also performs more tests per reagent bottle, reducing the frequency of bottle changes, minimising plastic waste, and reducing logistical efforts compared to previous generation systems.

By automating work that would have been done manually in the past, these new units further improve lab efficiency, thus addressing the shortage of qualified staff and increasing the volume of tests.

Launched in 2018, cobas pro integrated solutions is a scalable and modular solution designed to meet mid-to-very-high volume clinical chemistry and immunochemistry testing needs. It aims to increase efficiency with fast analytical units, intelligent sample routing, and short assay incubation times, with 93% of Roche immunoassays having reaction times of 18 minutes or less. This analyser features automated maintenance and cobas AutoCal, an automated calibration procedure, to save hands-on time. Additionally, it incorporates cobas SonicWash, an ultrasonic probe cleaning to ensure sample integrity.

cobas pro integrated solutions provides fully standardised results and operation to cobas pure integrated solutions. Together, they deliver a seamless experience and the highest level of standardisation using the same reagents and assay menu, delivering consistent results and operation, and therefore allowing for flexible staff assignment and minimal training needs. This also makes the systems ideal candidates for integrated health networks and lab chains.

cobas pro integrated solutions is fully compatible with the cobas mobile solution, a tablet that integrates multiple Roche applications, allowing laboratory professionals to interact with the analyser from anywhere in the lab.

With cobas pro integrated solutions, the required sample volume per test has been reduced on average by 43% compared to previous generation systems. Additionally, the plastic generated per test result has been reduced by up to 78% due to smaller reagent pack sizes and a higher number of tests per pack.

Designed to seamlessly integrate into clinical chemistry and immunochemistry testing, Roche’s innovative mass spectrometry analyser will also be available as part of the cobas pro integrated solutions in the near future.